CHELMSFORD, Mass., April 6, 2020 /PRNewswire/ -- Brooks Automation,
Inc. (Nasdaq: BRKS) today announced that Erica McLaughlin
has been elected to its Board of Directors. Ms. McLaughlin, Senior
Vice President and CFO of Cabot Corporation, joins the board and
the audit committee, bringing deep leadership experience as a
global public company CFO and a background in public
accounting.
"We are excited and honored to have Erica join our Board,"
said Steve Schwartz, President and CEO of Brooks. "She brings
experience as a strong leader in strategy and finance with a large
global organization such as Cabot Corporation. Erica will be an
invaluable asset to the Board and to Brooks as we continue on our
journey of growth and transformation to higher value."
Joseph R. Martin, Chairman of the
Brooks Board of Directors, also commented, "I am delighted to
welcome Erica to our Board. She will bring a unique
perspective to our Board based on her broad experience and
executive leadership roles at Cabot, and she will be a strong
contributor to our audit committee."
Ms. McLaughlin has been with Cabot Corporation since 2002 in a
variety of finance roles of increasing responsibility culminating
in her current position as Chief Financial Officer. Prior to
Cabot, Ms. McLaughlin worked for KPMG, LLP in their audit services
group. She earned an MBA and BS in Accounting from
Boston College. She also served on the
Board of Directors of the Cabot Boston Credit Union from 2013
through 2016 and currently serves as an executive leader for
Cabot's Diversity and Inclusion Steering Committee.
About Brooks Automation
Brooks (Nasdaq: BRKS)
is a leading provider of life science sample-based solutions and
semiconductor manufacturing solutions worldwide. The Company's
Life Sciences business provides a full suite of reliable cold-chain
sample management solutions and genomic services across areas such
as drug development, clinical research and advanced cell therapies
for the industry's top pharmaceutical, biotech, academic and
healthcare institutions globally. Brooks Life Sciences'
GENEWIZ division is a leading provider of DNA gene sequencing and
gene synthesis services. With over 40 years as a partner to the
semiconductor manufacturing industry, Brooks is a provider of
industry-leading precision vacuum robotics, integrated automation
systems and contamination control solutions to the world's leading
semiconductor chip makers and equipment manufacturers. Brooks
is headquartered in Chelmsford,
MA, with operations in North
America, Europe and
Asia. For more information, visit www.brooks.com.
"Safe Harbor Statement" under Section 21E of the Securities
Exchange Act of 1934
Some statements in this release are
forward-looking statements made under Section 21E of the Securities
Exchange Act of 1934. These statements are neither promises nor
guarantees but involve risks and uncertainties, both known and
unknown, that could cause Brooks' financial and business results to
differ materially from our expectations. They are based on the
facts known to management at the time they are made. These
forward-looking statements include but are not limited to
statements regarding the excepted impact and benefits of Ms.
McLaughlin's appointment to our Board of Directors. Factors that
could cause results to differ from our expectations include the
following: the volatility of the industries the Company
serves, particularly the semiconductor industry; our possible
inability to meet demand for our products due to difficulties in
obtaining components and materials from our suppliers in required
quantities and of required quality; risks and uncertainties related
to the coronavirus originating in Wuhan,
China and its effects on the Company's operations in
China, including supply chain, and
the operations of our customers in China; the inability of customers to make
payments to us when due; the timing and effectiveness of cost
reduction and cost control measures; price competition; disputes
concerning intellectual property; uncertainties in global political
and economic conditions, and other factors and other risks,
including those that we have described in our filings with the
Securities and Exchange Commission, including but not limited to
our Annual Report on Form 10-K, current reports on Form 8-K and our
quarterly reports on Form 10-Q. As a result, we can provide no
assurance that our future results will not be materially different
from those projected. Brooks expressly disclaims any obligation or
undertaking to release publicly any updates or revisions to any
such statement to reflect any change in our expectations or any
change in events, conditions or circumstances on which any such
statement is based. Brooks undertakes no obligation to update the
information contained in this press release.
INVESTOR CONTACTS:
Mark Namaroff
Director, Investor Relations
Brooks Automation
978.262.2635
mark.namaroff@brooks.com
Sherry Dinsmore
Brooks Automation
978.262.2400
sherry.dinsmore@brooks.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/brooks-automation-names-erica-mclaughlin-to-its-board-of-directors-301035433.html
SOURCE Brooks Automation